0001567619-19-006113.txt : 20190305
0001567619-19-006113.hdr.sgml : 20190305
20190305145709
ACCESSION NUMBER: 0001567619-19-006113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190304
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROWLAND LLOYD A
CENTRAL INDEX KEY: 0001236395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 19657852
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2019-03-04
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001236395
ROWLAND LLOYD A
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BOULEVARD, SUITE 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
General Counsel
Common Stock
2019-03-04
4
P
0
9000
10.33
A
9979
D
/s/ Lloyd Rowland
2019-03-05